Additional file 2: Table S2. of Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS) MuenzerJoseph GiuglianiRoberto ScarpaMaurizio Tylki-SzymańskaAnna JegoVirginie BeckMichael 2017 Median urinary glycosaminoglycan (uGAG) levels and median changes from baseline in uGAG levels in patients with data available at consecutive timepoints (year 1, year 2 and year 3 of treatment with idursulfase) (DOCX 22 kb)